Geneos Therapeutics
PrivateLast Round
Series A
Extension
Sep 27, 2023
Est. Valuation
$67M
Total Funding Raised
$54.5M
Company Overview
Geneos Therapeutics is a biotechnology company that develops DNA-based personalized immunotherapies for cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Geneos Therapeutics Comparables
Compare Geneos Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Nouscom | 84% | |
| Nexoplex Bio | 78% | |
| Evaxion A/S | 78% | |
Geneos Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Sep 27, 2023 | ||||
| Series A Extension | Apr 12, 2023 | ||||
| Series A Extension | Mar 24, 2022 | ||||
| Series A Extension | Mar 3, 2021 | ||||
| Series A | Feb 21, 2019 |
Geneos Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Shanghai Healthcare Capital | Series A Extension |
| 3B FUTURE Health Fund | Series A Extension |
| Flerie Invest | Series A Extension |
| Santé Ventures | Series A Extension, Series A |
| Santé Ventures | Series A Extension, Series A |
| Korea Investment Partners | Series A Extension |
| Flerie AB | Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 27, 2023
$10M round led by Shanghai Healthcare Capital
- Mar 24, 2022
$17M round led by Flerie Invest.
Geneos Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Geneos Therapeutics's valuation, stock price, and market status.